<?xml version="1.0" encoding="UTF-8"?>
<p>It has been suggested that the increase of extracellular glutamate occurs mainly due to an anomaly in glutamate transporter EAAT2/GLT-1 and leads to ALS. Harmine, a beta-carboline alkaloid, may act by activating EAAT2/GLT-1 gene expression increasing the cellular uptake of glutamate [
 <xref rid="B29" ref-type="bibr">29</xref>]. The indirect mechanism was suggested by the use of alkaloids with commercial drug Riluzole, aiming to block the increased levels of P-glycoprotein in the blood-brain barrier (BBB) [
 <xref rid="B30" ref-type="bibr">30</xref>]. In this sense, Lopez and Martinez-Luis showed that polyaromatic alkaloids from 
 <italic>prosobranch</italic> mollusk (
 <italic>Lamellaria</italic> sp.) restrain P-gp, demonstrating an increased cellular uptake to different drugs in resistant cell line [
 <xref rid="B31" ref-type="bibr">31</xref>]. However, in this review, we will highlight the benefits of its mechanism of action as antioxidants, since alkaloids have the ability to convert free radical species in inactive substances [
 <xref rid="B32" ref-type="bibr">32</xref>, 
 <xref rid="B33" ref-type="bibr">33</xref>]. Thus, researches have explored the advantages of employing alkaloids with this purpose, alone or included in a pharmaceutical form and from several sources [
 <xref rid="B34" ref-type="bibr">34</xref>â€“
 <xref rid="B37" ref-type="bibr">37</xref>].
</p>
